MASAI: AI-assisted mammography screening in a randomized trial
In the initial analysis of 80,033 women, AI-assisted screening detected 244 cancers versus 203 with standard double reading and reduced the reading workload by 44%. A Lund update on January 30, 2026, after more than two years and about 106,000 women, reports higher sensitivity without more false positives. The comparison is in a Swedish setting; it does not demonstrate reduced mortality.
Technology: AI for mammogram triage and marking
Publication: Publication status unspecified in annotation · Test context: prospective or independent check. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Not reported
- Test type: prospective or independent check
- Tested: A prospective randomized single-site trial compared AI-supported screening (about 40,003 women) with standard double reading (about 40,030 women), measuring cancers detected, false positives and radiologist workload.
- Still unknown: The Lund article states limits: single site, no mortality outcomes, and the main analysis awaits two-year follow-up; the January 2026 update could not be verified on the page read.
- AI role: AI flagged higher-risk mammography exams for two physicians or marked suspicious findings for a single reader.
Evidence sources: https://www.lu.se/artikel/ai-stodd-modell-saker-mammografiscreening
The legacy label “Not reported” does not distinguish information absent from reviewed material from information not assessed. It is not a scientific finding of absence.
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: press release. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Editorial assessment: Impact 4/5 · Validation 4/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.